Search results: Sage Journals

Restricted accessOtherFirst published January, 2008

Assessing the Performance of the EMEA's Centralized Procedure: A Comparative Analysis with the US FDA

Laura B. Faden, Kenneth I. Kaitin

Therapeutic Innovation & Regulatory Science

Restricted accessResearch articleFirst published July, 2000

Determining Warning Label Content and Format Using Emea

Mark R. Lehto

Proceedings of the Human Factors and Ergonomics Society Annual Meeting

Restricted accessResearch articleFirst published February, 2001

Orphan medicinal products – The role of the EMEA

Patrick Le Courtois, Melanie Carr

Pharmaceuticals Policy and Law

Restricted accessOtherFirst published January, 2006

Dialogue between Companies and the EMEA regarding the Centralized Procedure from an Industry's Point of View

Karin Heidenreich

Therapeutic Innovation & Regulatory Science

Restricted accessOtherFirst published October, 1999

The European Agency for the Evaluation of Medicinal Products' Centralized Procedure for Product Approval: Current Status

Elaine M. Healy, Kenneth I. Kaitin

Therapeutic Innovation & Regulatory Science

Restricted accessOtherFirst published September, 2003

Nice timing for glitazones

Clifford J Bailey, Caroline Day, Andrew J Krentz

The British Journal of Diabetes & Vascular Disease

Restricted accessCase reportFirst published September, 2010

Enterprise-Wide Business-IT Engagement in An Empowered Business Environment: The Case of Fedex Express EMEA

Stijn Viaene, Steven De Hertogh

Journal of Information Technology

Restricted accessResearch articleFirst published January, 1997

A New and Fast Drug Approval System in Europe

Fernand Sauer

Therapeutic Innovation & Regulatory Science

Free accessResearch articleFirst published January, 2024

Conceptualizing the dark ride experience through the Dark Ride Cube: Evidence from the EMEA region

Pieter C. M. Cornelis, Wim Strijbosch, Philip Corsius

Journal of Hospitality & Tourism Research

Restricted accessResearch articleFirst published February, 1999

Role of the EMEA in accompanying product development

Fernand Sauer, Isabelle Moulon

Pharmaceuticals Policy and Law

Restricted accessOtherFirst published January, 2008

Assessing the Performance of the EMEA's Centralized Procedure: A Comparative Analysis with the US FDA

Laura B. Faden, Kenneth I. Kaitin

Therapeutic Innovation & Regulatory Science

Restricted accessResearch articleFirst published July, 2000

Determining Warning Label Content and Format Using Emea

Mark R. Lehto

Proceedings of the Human Factors and Ergonomics Society Annual Meeting

Restricted accessResearch articleFirst published February, 2001

Orphan medicinal products – The role of the EMEA

Patrick Le Courtois, Melanie Carr

Pharmaceuticals Policy and Law

Restricted accessOtherFirst published January, 2006

Dialogue between Companies and the EMEA regarding the Centralized Procedure from an Industry's Point of View

Karin Heidenreich

Therapeutic Innovation & Regulatory Science

Restricted accessOtherFirst published October, 1999

The European Agency for the Evaluation of Medicinal Products' Centralized Procedure for Product Approval: Current Status

Elaine M. Healy, Kenneth I. Kaitin

Therapeutic Innovation & Regulatory Science

Restricted accessOtherFirst published September, 2003

Nice timing for glitazones

Clifford J Bailey, Caroline Day, Andrew J Krentz

The British Journal of Diabetes & Vascular Disease

Restricted accessCase reportFirst published September, 2010

Enterprise-Wide Business-IT Engagement in An Empowered Business Environment: The Case of Fedex Express EMEA

Stijn Viaene, Steven De Hertogh

Journal of Information Technology

Restricted accessResearch articleFirst published January, 1997

A New and Fast Drug Approval System in Europe

Fernand Sauer

Therapeutic Innovation & Regulatory Science

Free accessResearch articleFirst published January, 2024

Conceptualizing the dark ride experience through the Dark Ride Cube: Evidence from the EMEA region

Pieter C. M. Cornelis, Wim Strijbosch, Philip Corsius

Journal of Hospitality & Tourism Research

Restricted accessResearch articleFirst published February, 1999

Role of the EMEA in accompanying product development

Fernand Sauer, Isabelle Moulon

Pharmaceuticals Policy and Law